Article
The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice.
Cancer research - 15 May 2008
Fereshteh Mark P, Tilli Maddalena T, Kim Sung Eun, Xu Jianming, O'Malley Bert W, Wellstein Anton, Furth Priscilla A, Riegel Anna T
Abstract excerpt
Overexpression of the oncogene amplified in breast cancer 1 (AIB1)/steroid receptor coactivator-3 (SRC-3) induces mammary tumorigenesis in mice. In breast cancer, high levels of AIB1/SRC-3 and the growth factor receptor HER2/neu predict resistance to endocrine therapy and poor outcome. However, a mechanistic relationship between AIB1/SRC-3 and HER2/neu in the development of breast cancer has not been shown. Here,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
